Rilonacept
Modify Date: 2024-01-01 18:11:15
Rilonacept structure
|
Common Name | Rilonacept | ||
|---|---|---|---|---|
| CAS Number | 501081-76-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RilonaceptRilonacept (Arcalyst), a dimeric fusion protein, is a interleukin 1 inhibitor. Rilonacept consists of the ligand-binding domains of the extracellular portions of the IL-1R components linked to the Fc portion of human IgG1. Rilonacept can be used for the research of cryopyrin-associated periodic syndromes[1]. |
| Name | Rilonacept |
|---|
| Description | Rilonacept (Arcalyst), a dimeric fusion protein, is a interleukin 1 inhibitor. Rilonacept consists of the ligand-binding domains of the extracellular portions of the IL-1R components linked to the Fc portion of human IgG1. Rilonacept can be used for the research of cryopyrin-associated periodic syndromes[1]. |
|---|---|
| Related Catalog | |
| Target |
IL-1 |
| In Vitro | Rilonacept 通过充当结合 IL-1β 并阻止其与细胞表面受体相互作用的可溶性诱饵受体来阻断 IL-1α 信号传导，从而减少炎症过程[1]。 |
| References |
| No Any Chemical & Physical Properties |